LDS/Medical Tests/Bordetella pertussis and Bordetella parapertussis, Molecular

Bordetella pertussis and Bordetella parapertussis, Molecular

Pertussis, commonly referred to as whooping cough, is a respiratory infection associated with sudden coughing attacks. B. pertussis and B. parapertussis are the organisms that cause pertussis infections in humans. This bacterium is spread via droplets from the excessive coughing of infected individuals. Humans are the sole reservoir for these organisms. It is reported that there may be up to 50 million cases of Pertussis worldwide (about 27,000 in the U.S.) per year with more than 90% in developing countries. Pertussis is responsible for approximately 300,000 deaths worldwide annually. Pertussis is typically a 6-week disease process that is broken up into three stages. These stages are catarrhal, paroxysmal, and convalescence. The catarrhal stage is the most infectious stage with nonspecific symptoms that include congested nose, sneezing, tearing, and low-grade fevers. The paroxysmal stage is the stage that is indicative of the characteristic “whoop” sounding cough, which can last for several minutes per episode. The final stage is the convalescence stage, which continues as a chronic cough. This stage can last for several weeks. The disease may take 10 weeks or more to run its course. Confirmation of B. pertussis and B. parapertussis is by culture, PCR, or serology and may take a long period of time to diagnose. Because of this, physicians should make a presumptive diagnosis based on a history of persistent cough with or without a whoop, vomiting after coughing, and/or absence or incomplete vaccination. Currently the “gold standard” testing methodology for B. pertussis and B. parapertussis is isolation of fastidious gram-negative coccobacillus in culture. Due to PCR’s specificity, sensitivity, and speed of results it is seen as a viable alternative in diagnosis.

  • Diagnosis of B. pertussis and B. parapertussis infection
  • Disease and treatment monitoring

Positive in:

  • B. pertussis and B. parapertussis infection

Note: A positive test indicates that DNA from Bordetella pertussis or parapertussis is present in the specimen. It should be noted that there may be some cross reaction with other strains of Bordetella.

Negative in:

  • Adenoviral respiratory infection
  • Mycoplasmal pneumonia
  • Chlamydial pneumonia
  • Respiratory syncytial virus infection

Not Detected.
 

 

Polymerase Chain Reaction (PCR) with FRET, Real-time PCR

Sputum samples, throat washes, and throat swabs are less desirable specimens because the sensitivity of detecting Bordetella DFA is less suitable. The preferred specimen is a nasopharyngeal aspirate (NPA) or nasopharyngeal swab (NSA) and are utilized to isolate the pertussis organism. Specimen is transported at ambient temperature. Transport time should not exceed 48 hours from collection.

Nasopharynx culture for *B. pertussis, B. pertussis* by DFA, Sputum Culture, *Bordetella pertussis* culture, throat culture *B. pertussis* and *B. parapertussis* serology for immune status evaluation.
Usually 1 day after receipt in reference laboratory.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login